 RED BANK, N.J. , June 3, 2022 PRNewswire -- Provention Bio, Inc. Nasdaq: PRVB, a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in a corporate presentation at the Jefferies Global Healthcare Conference on Wednesday, June 8 th 2022 at 9:00 am EST in New York City. 